These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 26395501

  • 1. Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study.
    Nam JL, Hunt L, Hensor EM, Emery P.
    Ann Rheum Dis; 2016 Aug; 75(8):1452-6. PubMed ID: 26395501
    [Abstract] [Full Text] [Related]

  • 2. Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study.
    Garcia-Montoya L, Nam JL, Duquenne L, Villota-Eraso C, Di Matteo A, Hartley C, Mankia K, Emery P.
    Arthritis Res Ther; 2022 Jan 18; 24(1):26. PubMed ID: 35042555
    [Abstract] [Full Text] [Related]

  • 3. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study.
    Rakieh C, Nam JL, Hunt L, Hensor EM, Das S, Bissell LA, Villeneuve E, McGonagle D, Hodgson R, Grainger A, Wakefield RJ, Conaghan PG, Emery P.
    Ann Rheum Dis; 2015 Sep 18; 74(9):1659-66. PubMed ID: 24728331
    [Abstract] [Full Text] [Related]

  • 4. Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis.
    Nam JL, Hensor EM, Hunt L, Conaghan PG, Wakefield RJ, Emery P.
    Ann Rheum Dis; 2016 Dec 18; 75(12):2060-2067. PubMed ID: 26802181
    [Abstract] [Full Text] [Related]

  • 5. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.
    Arthritis Rheum; 2008 Jan 18; 58(1):36-45. PubMed ID: 18163519
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.
    van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW.
    Arthritis Rheum; 2004 Mar 18; 50(3):709-15. PubMed ID: 15022309
    [Abstract] [Full Text] [Related]

  • 7. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP.
    J Clin Rheumatol; 2006 Aug 18; 12(4):172-5. PubMed ID: 16891919
    [Abstract] [Full Text] [Related]

  • 8. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
    Gossec L, Paternotte S, Combe B, Meyer O, Dougados M.
    J Rheumatol; 2014 Jan 18; 41(1):41-6. PubMed ID: 24241481
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
    Ramos-Remus C, Castillo-Ortiz JD, Aguilar-Lozano L, Padilla-Ibarra J, Sandoval-Castro C, Vargas-Serafin CO, de la Mora-Molina H, Ramos-Gomez A, Sanchez-Ortiz A, Avila-Armengol H, Aceves-Avila FJ.
    Arthritis Rheumatol; 2015 Nov 18; 67(11):2837-44. PubMed ID: 26245885
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY, Yang CT, Cheng CH, Yu KH.
    Int J Rheum Dis; 2016 Sep 18; 19(9):880-6. PubMed ID: 25940989
    [Abstract] [Full Text] [Related]

  • 11. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 18; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 12. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
    Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, Fraser A, Emery P.
    Rheumatology (Oxford); 2006 Apr 18; 45(4):478-80. PubMed ID: 16287917
    [Abstract] [Full Text] [Related]

  • 13. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D.
    Arthritis Rheum; 2013 Apr 18; 65(4):911-5. PubMed ID: 23279976
    [Abstract] [Full Text] [Related]

  • 14. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, Batteux F, Dougados M, Kahan A, Allanore Y.
    J Rheumatol; 2014 Dec 18; 41(12):2395-402. PubMed ID: 25274898
    [Abstract] [Full Text] [Related]

  • 15. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
    Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G.
    Ann Rheum Dis; 2005 Dec 18; 64(12):1731-6. PubMed ID: 15878904
    [Abstract] [Full Text] [Related]

  • 16. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct 18; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 17. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 18; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.
    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.
    Arthritis Res Ther; 2005 Apr 18; 7(5):R949-58. PubMed ID: 16207336
    [Abstract] [Full Text] [Related]

  • 19. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.
    Arthritis Rheum; 2004 Jul 18; 50(7):2113-21. PubMed ID: 15248208
    [Abstract] [Full Text] [Related]

  • 20. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
    Bos WH, Ursum J, de Vries N, Bartelds GM, Wolbink GJ, Nurmohamed MT, van der Horst-Bruinsma IE, van de Stadt RJ, Crusius JB, Tak PP, Dijkmans BA, van Schaardenburg D.
    Ann Rheum Dis; 2008 Sep 18; 67(9):1347-50. PubMed ID: 18388157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.